About Esteve
Esteve is a company based in Barcelona (Spain) founded in 1929. Esteve has completed 3 acquisitions, including HRA Pharma Rare Diseases, RIEMSER Pharma and Regis Technologies.
- Headquarter Barcelona, Spain
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
HRA Pharma Rare Diseases
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Esteve
Unlock access to complete
Unlock access to complete
Leadership Team
25 people
Software Development Team
20 people
Human Resources and Administration
7 people
Finance and Accounting
6 people
Sales and Marketing
6 people
Global Team
5 people
Product Management Team
4 people
Operations Team
3 people
Unlock access to complete
Funding Insights of Esteve
Investments & Acquisitions by Esteve
Esteve has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include HRA Pharma Rare Diseases, RIEMSER Pharma and Regis Technologies.
Investment portfolio details for Esteve
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Contract development and manufacturing services for pharmaceutical APIs are provided.
|
Locked | Locked | 2000 | Locked | |
|
Pharmaceutical solutions for rare and ultra-rare diseases are developed.
|
Locked | Locked | 1996 | Locked | |
|
Offers CDMO and bioanalytical services for APIs and Highly potent APIs and proprietary chromatography products for chiral applications
|
Locked | Locked | 1956 | Locked |
Complete acquisition details for Esteve
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Esteve
Detailed financials for Esteve
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Esteve Comparisons
Peer comparison for Esteve
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Esteve
Detailed competitors of Esteve
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Esteve
Complete news archive for Esteve
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Esteve
Esteve was founded in 1929 and raised its 1st funding round 94 years after it was founded.
Esteve is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
Esteve was founded in 1929 and is based in Barcelona, Spain. Operations center on the pharmaceutical sector, with a focus on developing therapies for chronic pain management. The lead candidate, E-58425, is an orally administered agent that targets pain receptors and is under investigation for severe acute and chronic pain conditions. Research and development activities are conducted to advance these treatments.
Esteve has made 3 acquisitions, including HRA Pharma Rare Diseases, RIEMSER Pharma, and Regis Technologies.